rs45517179
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(C;C) | 0 | common in clinvar |
(C;T) | 6.3 | Tuberous Sclerosis Complex |
(T;T) | 5 | Tuberous sclerosis |
Reference | GRCh38 38.1/141 |
Chromosome | 16 |
Position | 2064341 |
Gene | TSC2 |
is a | snp |
is | mentioned by |
dbSNP | rs45517179 |
dbSNP (classic) | rs45517179 |
ClinGen | rs45517179 |
ebi | rs45517179 |
HLI | rs45517179 |
Exac | rs45517179 |
Gnomad | rs45517179 |
Varsome | rs45517179 |
LitVar | rs45517179 |
Map | rs45517179 |
PheGenI | rs45517179 |
Biobank | rs45517179 |
1000 genomes | rs45517179 |
hgdp | rs45517179 |
ensembl | rs45517179 |
geneview | rs45517179 |
scholar | rs45517179 |
rs45517179 | |
pharmgkb | rs45517179 |
gwascentral | rs45517179 |
openSNP | rs45517179 |
23andMe | rs45517179 |
SNPshot | rs45517179 |
SNPdbe | rs45517179 |
MSV3d | rs45517179 |
GWAS Ctlg | rs45517179 |
Max Magnitude | 6.3 |
rs45517179 is a SNP in the TSC2 gene on chromosome 16, associated with tuberous sclerosis in an autosomal dominant manner.[PMID 9463313]
This variant meets the criteria published in 2013 by the ACMG regarding incidental findings in exome or genome sequencing, as a variant that they do recommend informing a patient about.[PMID 23788249]
See also OMIM 191092.0005
ClinVar | |
---|---|
Risk | Rs45517179(T;T) |
Alt | Rs45517179(T;T) |
Reference | Rs45517179(C;C) |
Significance | Pathogenic |
Disease | Tuberous sclerosis 2 Tuberous sclerosis syndrome Lymphangiomyomatosis |
Variation | info |
Gene | TSC2 |
CLNDBN | Tuberous sclerosis 2 Tuberous sclerosis syndrome Lymphangiomyomatosis |
Reversed | 0 |
HGVS | NC_000016.9:g.2114342C>T |
CLNSRC | OMIM Allelic Variant Tuberous sclerosis database (TSC2) |
CLNACC | RCV000013204.24, RCV000043399.2, RCV000055539.1, |
[PMID 16981] [Standard method for the determination of creatine kinase activity].
[PMID 10205261] Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.
[PMID 16114042] Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
[PMID 16981987] Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.